期刊文献+

肝脏不典型增生结节20例诊治及预后分析 被引量:2

Hepatic dysplastic nodules:A management and prognostic analysis of 20 cases
原文传递
导出
摘要 目的总结肝脏不典型增生结节(HDN)病例的临床、病理特点及治疗经验。方法回顾性分析2002年10月至2014年12月北京协和医院收治的20例HDN病人临床资料,总结临床特征并进行随访。结果所有病人均行手术,且术后恢复良好。术后大体病理检查中仅1例病人肿物边界不完整。12例HDN病人合并肝硬化。病理诊断:10例为单纯HDN,1例为HDN合并局灶性结节性增生,7例为HDN合并HCC,1例为HDN合并灶性癌变,1例为HDN合并肝细胞腺瘤。术后1例失访。5例HDN合并癌变病人术后6~24个月肝癌复发,其余病人术后随访至2015年1月无复发。结论 HDN可能是具有相对良好预后的癌前病变,如发生癌变则将改变预后,应密切随访,病史、肿瘤标记物及影像学检查有助于诊断,对于难以鉴别或怀疑性质改变时可考虑积极手术处理。 Objective To summarize the clinical and pathological characteristics as well as management experience of hepatic dysplastic nodule (HDN). Methods The clinical data and follow-up results of 20 cases of HDN treated from October 2002 to December 2014 in Peking Union Medical College Hospital were analyzed retrospectively. Results All cases underwent operation, and the postoperative recovery was good. In postoperative pathological examination, only 1 case of tumor boundary was ambiguous; 12 cases combined with liver cirrhosis. Pathological diagnosis: 10 cases of simple HDN, 1 case of HDN complicated with focal nodular hyperplasia, 7 cases of HDN complicated with HCC, 1 case of HDN complicated with focal lesions, 1 case of HDN complicated with liver cell adenoma. In the postoperative follow-up, 1 case was lost. 5 cases of HDN complicated with canceration recurrented hepatocellular carcinoma after 6-24 months. The rest of the cases were followed up to January 2015 without recurrence. Conclusion HDN might be a precancerous lesion with relatively good prognosis while carcinogenesis would change prognosis. So the intensive following-up is necessary. Medical history, tumor markers and imaging are helpful for the diagnosis. Surgical resection should be considered when nodules are difficult to differentiate or hepatocarcinogenesis have occurred.
出处 《中国实用外科杂志》 CSCD 北大核心 2015年第5期525-527,共3页 Chinese Journal of Practical Surgery
关键词 肝脏肿瘤 不典型增生结节 肝细胞癌 肝切除术 liver tumor dysplastic nodule hepatocellular carcinoma hepatectomy
  • 相关文献

参考文献11

  • 1International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Groupfor Hepatocellular Neopla- sia [J]. Hepatology, 2009,49(2):658-664. 被引量:1
  • 2Park YN.Update on precursor and early lesions of hepatocellular carcinomas [ J ]. Arch Pathol Lab Med, 2011,135 (6): 704-715. 被引量:1
  • 3Jin GZ, Dong H, Yu WL, et al. A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values[J]. BMC Cancer,2013,13:161. 被引量:1
  • 4Giorgio A, Calisti G, di Samo A, et al. Characterization of dys- plastic nodules, early hepatocellular carcinoma and progressed hepatocellular carcinoma in cirrhosis with contrast-enhanced ul- trasound [ J ]. Anticancer Res, 2011,31 (11):3977-3982. 被引量:1
  • 5International Consensus Group for Hepatoeellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neopla- sia [J]. Hepatology, 2009,49(2):658-664. 被引量:1
  • 6Gong L, Wei LX, Ren P, et al. Dysplastic nodules with glypi- can-3 positive immunostaining: a risk for early hepatocellular carci [J]. PLoS One, 2014,9(1):e87120. 被引量:1
  • 7Ouedraogo NA, Danjoux-de-Volontat M, Auriol J, et ahDysplastic hepatic nodules: radiological abnormalities and histopatho- logical correlations [J ]. Eur J Radiol, 2011,79(2):232-236. 被引量:1
  • 8Kudo M, Izumi N, Kokudo N, et al. HCC expert panel of japan society of hepatology. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the japan society of hepatology (JSH) 2010 updated version [J]. Dig Dis, 2051,29(3):339-364. 被引量:1
  • 9Quaia E, De Paoli L, Pizzolato R, et al. Predictors of dysplastic nodule diagnosis in patients with liver cirrhosis on unenhanced and gadobenate dimeglumine-enhanced MRI with dynamic and hepatohiliary phase [J]. Am J Roentgenol, 2013, 200(3): 553-562. 被引量:1
  • 10Bruix J, Sherman M. Management of hepatocellular carcinoma [ J ]. Hepatology, 2005,42(5): 1208-1236. 被引量:1

二级参考文献25

  • 1Xu HX, Liu GJ, Lu MD, et al.Characterization of small focal liv- er lesions using real-time contrast-enhanced sonography: diag- nostic performance analysis in 200 patients [J].J Ultrasound Med, 2006,25(6): 349-361. 被引量:1
  • 2Borzio M, Fargion S, Borzio F, et al. Impact of large regenerative, low grade and high grade dysplastic nodules in hepatocellular carcinoma development [ J ] .J Hepatol, 2003,39(2) : 208-214. 被引量:1
  • 3Song B. Imaging and related pathology of liver nodular diseases [ J ].Radiol Pract, 2006,18(9) : 674-680. 被引量:1
  • 4Jemal A, Siegel R, Ward E, et al.Cancer statistics, 2008 [J].CA Cancer J Clin, 2008,58(2) : 71-96. 被引量:1
  • 5Papatheodoridis GV, Lampertico P, Manolakopoulos S, et al.In- cidence of hepatocellular carcinoma in chronic hepatitis B pa- tients receiving nucleostide therapy: a systematic review [J].Journal of Hepatalogy, 2010,53(2) : 348-356. 被引量:1
  • 6Bosch FX, Ribes J, Diaz M, C16ries R.Primary liver cancer: worldwide incidence and trends [J].Gastroenterology, 2004, 127 (5 Suppl 1):5-16. 被引量:1
  • 7International Consensus Group for Hepatocellular Neoplasia. Pathologic diagnosis of early hepatocellular carcinoma: a report of the International Consensus Group for Hepatocellular Neopla- sia[ J ] .Hepatology, 2009,49(2) : 658-664. 被引量:1
  • 8Lira JH, Kim M J, Park CK, et al. Dysplastic nodules in liver cir- rhosis:detection with triple phase helical dynamic CT [J ].Brit J Radiol, 2004,77(923) : 911-916. 被引量:1
  • 9Seki S, Sakaguchi H, Kitada T, et al. Outcomes of dysplastic nodules in human cirrhotic liver: a clinicopathological study [J]. Clin Cancer Res, 2000,6(9) : 3469-3473. 被引量:1
  • 10Iavarone M, Manini MA, Sangiovanni A, et ahContrast-en- hanced computed tomography and ultrasound-guided liver bi- opsy to diagnose dysplastie liver nodules in cirrhosis [J].Dig Liver Dis, 2013,45(1) :43-49. 被引量:1

共引文献8

同被引文献23

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部